InsiderTrades

Form 4 for IDYA IDEAYA Biosciences, Inc.

Accepted 2024-06-27 00:00:00 ET · period of report 2024-06-27 · accession 0001610717-24-000367 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-27 2024-06-27 IDYA Throne Jason CLO M - OptEx $7.77 +53.5K 16.4K New +$415.6K
DM 2024-06-27 2024-06-27 IDYA Throne Jason CLO M - OptEx $0.00 -53.5K 1,360 -98% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-27 M A 47,060 $7.01 63,484 D — —
2 Common Common Stock 2024-06-27 M A 6,424 $13.34 16,424 D — —
3 Derivative Stock Option (Right to Buy) 2024-06-27 M D 6,424 $0.00 41,186 D $13.34 · — to 2030-06-30 6,424 Common Stock (F1) 25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
4 Derivative Stock Option (Right to Buy) 2024-06-27 M D 47,060 $0.00 1,360 D $7.01 · — to 2029-10-08 47,060 Common Stock (F2) The shares subject to the option are fully vested and exercisable.